STOCK TITAN
  1. Home
  2. Sec-filings
  3. VTVT
  4. [EFFECT] vTv Therapeutics Inc. SEC Filing

[EFFECT] vTv Therapeutics Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 24, 2025 4:00 P.M.
Form: S-3
CIK: 0001641489
Company Name: vTv Therapeutics Inc.
File Number: 333-290709

Source: View Original Filing on SEC EDGAR

Stock VTVT logo
Vtv Therapeutics

NASDAQ:VTVT

VTVT Rankings

#4712 Ranked by Market Cap
N/A Ranked by Dividends

VTVT Latest News

Dec 18, 2025
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
Nov 6, 2025
vTv Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Oct 9, 2025
vTv Therapeutics Announces New Appointments to its Scientific Advisory Board
Sep 15, 2025
vTv Therapeutics Will Participate in INNODIA Symposium at the EASD 61st Annual Meeting
Sep 3, 2025
UPDATE -- vTv Therapeutics to Participate in Upcoming September Investor Conferences

VTVT Latest SEC Filings

Nov 6, 2025
[8-K] vTv Therapeutics Inc. Reports Material Event
Nov 6, 2025
[10-Q] vTv Therapeutics Inc. Quarterly Earnings Report
Oct 3, 2025
[S-3] vTv Therapeutics Inc. Shelf Registration Statement
Sep 25, 2025
[SCHEDULE 13D/A] vTv Therapeutics Inc. SEC Filing
Sep 25, 2025
[Form 4] vTv Therapeutics Inc. Insider Trading Activity

VTVT Stock Data

146.69M
3.01M
35.51%
39.63%
0.56%
Biotechnology
Pharmaceutical Preparations
Link
United States
HIGH POINT